Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis

Journal of Clinical Rheumatology

Volumn 12, Issue 5, 2006, Pages 226-229

  Candia, Liliana ^a,c   Marquez, Javier ^a   Gonzalez, Cesar ^b   Santos, Ana Maria ^b   Londoño, John ^b   Valle, Rafael ^b   Zabaleta, Jovanny ^a   Yaqub, Zunera ^a   Espinoza, Luis R ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOSPITAL MILITAR CENTRAL   (Colombia)

^c Edificio Terraverde ^*  (Colombia)

Author keywords

Anti CCP in psoriatic arthritis but not in psoriasis; Anti CCP psoriasis; Osteoarthritis; Psoriatic arthritis; Rheumatoid factor; Undifferentiated arthritis

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR;

ADULT; AGED; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FOLLOW UP; GENDER; HUMAN; INFLAMMATORY DISEASE; INTERPHALANGEAL JOINT; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SERODIAGNOSIS;

ADULT; ANTIBODIES; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; PEPTIDES, CYCLIC; PSORIASIS;

EID: 33749524684     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/rhu.0000242779.73390.51     Document Type: Article

References (17)

1. Schellekens GA, Visser H, de Jong BA, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 2000;43:155-163.
2. Bombardieri M, Alessandri C, Labbadia G, et al. Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement. Arthritis Res Ther. 2004;6:137-141.
3. Kasapcopur O, Altun S, Aslan M, et al. Diagnostic accuracy of anticyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann Rheum Dis. 2004;63:1687-1689.
4. Salvador G, Gomez A, Viñas O, et al. Prevalence and clinical significance of anti-cyclic citrullinated peptide and antikeratin antibodies in palindromic rheumatism. An abortive form of rheumatoid arthritis? Rheumatology. 2003;42:972-975.
5. Gottenberg JE, Mignot S, Nicaise-Rolland P, et al. Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome. Ann Rheum Dis. 2005;64:114-117.
6. Van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum. 2004;50:709.
7. Raza K, Breese M, Nightingale P, et al. Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis. J Rheumatol. 2005;32:231-238.
8. Bogliolo L, Alpini C, Caporali R, et al. Antibodies to cyclic citrullinated peptides in psoriatic arthritis. J Rheumatol. 2005;32:511-515.
9. Cruyssen BV, Hoffman IEA, Zmierczak H, et al. Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis. Ann Rheum Dis. 2004; E-pub.
10. Korendowych E, Owen P, Ravindran J, et al. The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis. Rheumatology (Oxford). 2005;44:1056-1060.
11. Alenius GM, Berglin E, Rantapaa Dahlqvist S. Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without manifestation of joint inflammation. Ann Rheum Dis. 2005; E-pub.
12. Altman R, Alarcon G, Appelrouth D, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum. 1990;33:1601-1610.
13. Altman R, Alarcon G, Appelrouth D, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum. 1991;34:505-514.
14. Altman R, Asch E, Bloch G, et al. Development of criteria for the classification and reporting of osteoarthritis of the knee. Arthritis Rheum. 1986;29:1039-1049.
15. Vossenar ER, Smeets TMJ, Kraan MC, et al. The presence of citrullinated proteins is not specific for rheumatoid synovial tissue. Arthritis Rheum. 2004;50:3485-3494.
16. De Rycke L, Nicholas AP, Cantaert T, et al. Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity. Arthritis Rheum. 2005;52:2323-2330.
17. Mcgonagle D, Conaghan PG, Emery P. Psoriatic arthritis: a unified concept twenty years on. Arthritis Rheum. 1999;42:1080-1086.